Evidence map›Paper›PMID 32033232›Full record

ArticleBiomolecules2020

Permanent Photodynamic Activation of the Cholecystokinin 2 Receptor.

Wen Zhu Tang, Zong Jie Cui

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wen Zhu TangInstitute of Cell Biology, Beijing Normal University, Beijing 100875, China.
Zong Jie CuiInstitute of Cell Biology, Beijing Normal University, Beijing 100875, China.
Beijing Normal University · CN

Funding

The Natural Science Foundation of China 31670856, 31971170
6 · The paper itself

Abstract

The cholecystokinin 2 receptor (CCK2R) is expressed in the central nervous system and peripheral tissues, playing an important role in higher nervous and gastrointestinal functions, pain sensation, and cancer growth. CCK2R is reversibly activated by cholecystokinin or gastrin, but whether it can be activated permanently is not known. In this work, we found that CCK2R expressed ectopically in CHO-K1 cells was permanently activated in the dark by sulfonated aluminum phthalocyanine (SALPC / AlPcS4, 10-1,000 nM), as monitored by Fura-2 fluorescent calcium imaging. Permanent CCK2R activation was also observed with AlPcS

Indexed as

AnimalsCalciumCalcium SignalingCHO CellsCricetulusHumansIndolesLightOrganometallic CompoundsPhotochemotherapyPhotosensitizing AgentsReceptor, Cholecystokinin Baluminum tetrasulfophthalocyanineCalciumIndolesOrganometallic CompoundsPhotosensitizing AgentsReceptor, Cholecystokinin Bcalcium oscillationsCCK2RminiSOGphotodynamic actionSALPC

Identifiers

PMID32033232
PMCPMC7072308
OpenAlexW3005332917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.